Skip Navigation

Equilibre Biopharmaceuticals

Leading the Discovery, Development, and Delivery of Breakthrough Neurological Therapeutics

  • CEO: Samuel Waksal
  • Location: New York, NY
  • Milestones: Nov 2020 - Third Point Ventures initial investment
Go to site

A biotechnology company focused on treating treatment resistant Epilepsy and other neurological disorders.